Emerging Biotech achieves successful European launch with support of Orphan Drug Consulting’s comprehensive approach to navigating diverse market landscape and EU regulations
As rare disease companies continue to face the challenge of entering new markets without adequate infrastructure build and knowhow, Orphan Drug Consulting experts recently supported one such company with an accelerated launch into the EU market. Using its cross-functional team and proven approach, Orphan Drug Consulting enabled early access of the client’s treatment to patients
Read more
